IQPC Cell & Gene Therapy Conference, Oct 29-31

| News, USA

The Conference to address process development, technical adoption and manufacturing challenges

Meet Immatics at this year’s Cell & Gene Therapy Conference and get our latest news about the manufacturing of TCR-based T-cell therapies:

Wednesday, Oct 30 (Day 2), 9.45am – 10.20am

Manufacturing of TCR-based T-cell therapies for solid cancers to enable late stage clinical trials

Speaker: Zoe Coughlin, Associate Director CMC

All information about the IQPC Cell & Gene Therapy Conference can be found here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.